Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

US Patent 11590154 · Granted Feb 28, 2023

Estimated economic value: $568,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Serine protease inhibitor for treating coronavirus infection2025
Therapy for inhibition of single-stranded RNA virus replication2025
Biomarkers of coronavirus pneumonia2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection2024
Serine protease inhibitor for treating coronavirus infection2024
Method for eradicating Helicobacter pylori infection in patients regardless of b2024
Inhibitor of sphingosine kinase 2 for treating Ebola2023
Combination compositions for treatment of cancer2023
Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately 2022
Sphingosine kinase 2 inhibitor for treating coronavirus infection2022
Token-based transport rules2022